Impact of prior aspirin therapy on clinical manifestations of cardiovascular implantable electronic device infections | Zendy

Alim Habib | Zendy; Muhammad Irfan | Zendy; Larry M. Baddour | Zendy; K. Y. Le | Zendy; Namrata S Anavekar | Zendy; Christine M. Lohse | Zendy; Paul A. Friedman | Zendy; David L. Hayes | Zendy; Walter R. Wilson | Zendy; James M. Steckelberg | Zendy; M. Rizwan Sohail | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Impact of prior aspirin therapy on clinical manifestations of cardiovascular implantable electronic device infections

Author(s) -

Alim Habib,

Muhammad Irfan,

Larry M. Baddour,

K. Y. Le,

Namrata S Anavekar,

Christine M. Lohse,

Paul A. Friedman,

David L. Hayes,

Walter R. Wilson,

James M. Steckelberg,

M. Rizwan Sohail

Publication year - 2012

Publication title -

ep europace

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.119

H-Index - 102

eISSN - 1532-2092

pISSN - 1099-5129

DOI - 10.1093/europace/eus292

Subject(s) - medicine , aspirin , leukocytosis , chills , infective endocarditis , endocarditis , surgery

Cardiovascular implantable electronic device (CIED) infection may present as pocket infection or as infective endocarditis (CIED-IE) with vegetation on device leads or heart valves. As aspirin has both anti-inflammatory properties and interferes with platelet aggregation, we hypothesized that ongoing anti-platelet therapy with aspirin may impact clinical and echocardiographic manifestations of CIED infection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research